Outpatient treatment with intravenous antimicrobial therapy and oral levofloxacin in patients with febrile neutropenia and hematological malignancies

Annals of Hematology

Volumn 90, Issue 4, 2011, Pages 455-462

  Bellesso, Marcelo ^a   Costa, Silvia Figueiredo ^a   Pracchia, Luis Fernando ^a   Dias, Lucia Cristina Santos ^a   Chamone, Dalton ^a   Dorlhiac Llacer, Pedro Enrique ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Febrile neutropenia; MASCC; Outpatient treatment

Indexed keywords

ANTIINFECTIVE AGENT; CEFEPIME; CREATININE; LEVOFLOXACIN; TEICOPLANIN; CEPHALOSPORIN DERIVATIVE; OFLOXACIN;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RISK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEBRILE NEUTROPENIA; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; OUTCOME ASSESSMENT; OXYGEN SATURATION; PRIORITY JOURNAL; PULSE OXIMETRY; RETROSPECTIVE STUDY; SMOKING; TREATMENT FAILURE; TREATMENT RESPONSE; BLOOD DISEASE; FEVER; INFUSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; NEUTROPENIA; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; FEVER; HEMATOLOGIC NEOPLASMS; HOME INFUSION THERAPY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; NEUTROPENIA; OFLOXACIN; RETROSPECTIVE STUDIES; TEICOPLANIN; TREATMENT OUTCOME;

EID: 79955942934     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1073-3     Document Type: Article

References (28)

1. Bodey GP, Buckley M, Sathe YS, Freireich EJ (1966) Quantitative relationship between circulating leukocytes and infections in patients with acute leukemia. Ann Intern Med 64:328-340
2. Sickles EA, Greene WH, Wiernik PH (1975) Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 135:715-719
3. Schimpff S, Saterlee W, Young VM, Serpick A (1971) Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and neutropenia. N Engl J Med 284:1061-1065
4. Schimpff SC, Gaya H, Klastersky J, Tattersall MH, Zinner SH (1978) Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis 137:14-29 (Pubitemid 8263352)
5. Talcott JA, Finberg R, Mayer R, Goldman L (1988) The medical course of cancer patients with fever and neutropenia. Arch Intern Med 148:2561-2568
6. Talcott JA, Siegel RD, Finberg R, Goldman L (1992) Risk assessment in cancer patients with fever and neutropenia. A prospective, twocenter validation of a prediction rule. J Clin Oncol 10:316-322
7. Klastersky J, Paesmans M, Rubenstein EB, Boyer M, Elting L, Feld R, Gallagher J, Herrstedt J, Rapoport B, Rolston K, Talcott JA (2000) The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051 (Pubitemid 30644129)
8. Uys A, Rapoport BL, Anderson R (2004) Febrile neutropenia: a prospective study to validate the multinational association of supportive care of cancer (MASCC) risk-index score. Support Care Cancer 12:555-560 (Pubitemid 39062546)
9. Hughes WT, Armstrong D, Bodey GP, Bow EJ, Brown AE, Calandra T, Feld R, Pizzo PA, Rolston KV, Shenep JL, Young LS (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730-751 (Pubitemid 34194843)
10. Malik IA, Khan WA, Karim M, Aziz Z, Khan MA (1995) Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia-results of a prospective randomized trial. Am J Med 98:224-231
11. Kern WV, Cometta A, De Bock R, Langenaeken J, Paesmans M, Gaya H (1999) Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 341(5):312-318 (Pubitemid 29350301)
12. Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341(5):305-311 (Pubitemid 29350300)
13. Klastersky J, Paesmans M, Georgala A, Muanza F, Plehiers B, Dubreucq L, Lalamiet Y, Aoun M, Barette M (2006) Outpatient oral antibiotics for febrile neutropenia cancer patients using score predictive for complications. J Clin Oncol 24:4129-4134 (Pubitemid 46622289)
14. Girmenia C, Russo E, Carmosino I, Breccia M, Dragoni F, Latagliata R, Mecarocci S, Morano SG, Stefanizzi C, Alimena G (2007) Early hospital discharge with oral antimicrobial therapy in patients with hematologic malignancies and low-risk febrile neutropenia. Ann Hematol 86(4):263-270 (Pubitemid 46351401)
15. Cherif H, Johansson E, Björkholm M, Kalin M (2006) The feasibility of early hospital discharge with oral antimicrobial therapy in low risk patients with febrile neutropenia following chemotherapy for hematologic malignancies. Haematologica 91:215-222
16. De Lalla F (2003) Outpatient therapy for febrile neutropenia. Clinical and economic implications. Pharmacoeconomics 21:397-413
17. Bennett CL, Calhoun EA (2007) Evaluating the total costs of chemotherapy-induced febrile neutropenia: results from a pilot study with community oncology cancer patients. Oncologist 12(4):478-483 (Pubitemid 46698725)
18. Martino P, Girmenia C, Raccah R, Micozzi A, Cimino G, Sgadari C, Gentile G (1992) Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies. Oncology 4:49-52
19. Minotti V, Gentile G, Bucaneve G, Iori AP, Micozzi A, Cavicchi F, Barbabietola G, Landonio G, Menichetti F, Martino P, Del Favero (1999) A domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment. Support Care Cancer 7:134-139 (Pubitemid 29187560)
20. Girmenia C, Moleti ML, Cartoni C, Cedrone M, De Gregoris C, De Sanctis V, Giovannini M, Latagliata R, Niscola P, Romani C, Rondinelli MB, Tosti S, Mandelli F (1997) Management of infective complications in patients with advanced hematologic malignancies in home care. Leukemia 11:1807-1812 (Pubitemid 27485122)
21. Girmenia C, Latagliata R, Tosti S, Morano SG, Celesti F, Coppola L, Spadea A, Breccia M, Battistini R, Tafuri A, Cimino G, Mandelli F, Alimena G (1999) Outpatient management of acute promyelocytic leukemia after consolidation chemotherapy. Leukemia 13:514-517 (Pubitemid 29195277)
22. Girmenia C, Alimena G, Latagliata R, Morano SG, Celesti F, Coppola L, Spadea A, Tosti S, Mecarocci S, D'Elia G, Tafuri A, Cimino G, Mandelli F (1999) Outpatient management of acute myeloid leukemia after consolidation chemotherapy. Role of a hematologic emergency unit. Haematologica 84:814-819 (Pubitemid 29474371)
23. Petrilli AS, Dantas LS, Campos MC, Tanaka C, Ginani VC, Seber A (2000) Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial. Med Pediatr Oncol 34:87-91 (Pubitemid 30090470)
24. Viana LS, Serufo JC, Rocha MOC, Costa RN, Duarte RC (2008) Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer 16:841-846 (Pubitemid 351809802)
25. Talke P, Stapelfeldt C (2006) Effect of peripheral vasoconstriction on pulse oximetry. J Clin Monit Comput 20(5):305-309 (Pubitemid 44669313)
26. Lindberg LG, Lennmarken C, Vegfors M (1995) Pulse oxymetry - clinical implications and recent technical developments. Acta Anaesthesiol Scand 39:279
27. Mower WR, Sachs C, Nicklin EL, Safa P, Baraff LJ (1995) Effect of routine emergency department triage pulse oximetry screening on medical management. Chest 108(5):1297-1302
28. Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos M (2005) Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin. Cancer 103:2629-2635 (Pubitemid 40800544)